PARIS--(BUSINESS WIRE)--LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an ...

BioData has announced the roll-out of its Electronic Lab Notebook (ELN) platform, Labguru, with Inserm, France’s only public research institute to focus entirely on human health. Inserm made the ...

Please provide your email address to receive an email when new articles are posted on . Almirall S.A. and Inserm Transfert have entered an agreement to advance research in vitiligo treatment, the two ...

Partnership will expand Evotec's molecular patient database in the area of metabolic diseases and in particular obesity Evotec will leverage its leading PanOmics technologies for the generation of ...

Company gets first dibs on promising Inserm antibody projects for collaborative development and licensing. Innate Pharma negotiated a deal with Inserm, France’s health research agency, giving the ...

Global biopharmaceutical company, Almirall, and Inserm Transfert – the private subsidiary of the French National Institute of Health and Medical Research (Inserm) – have announced plans to collaborate ...

AstraZeneca and the French National Institute of Health and Medical Research (Inserm) have entered a collaboration to investigate new therapeutic approaches to type 2 diabetes and chronic kidney ...

Global artificial intelligence (AI) company, Expert System has announced that the French National Institute of Health and Medical Research, Inserm, will implement its Clinical Research Navigator (CRN) ...

Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to ...

BioData has announced the roll-out of its Electronic Lab Notebook (ELN) platform, Labguru, with Inserm, France’s only public research institute to focus entirely on human health. Inserm made the ...